2018 ESC/ESH guidelines about new methods of treatment of hypertension — “DEVICE-BASED TREATMENT”
https://doi.org/10.18705/1607-419X-2018-24-6-623-627
Abstract
Arterial hypertension (HTN) needs new treatment methods, including invasive ones, because HTN has severe consequences and involves all regulating systems (neuro-cardio-renal/cerebral continuum). It is often associated with comorbid pathology (obesity, atherosclerosis, sleep disorder, diabetes mellitus, etc.). The paper presents a summary of the position of the European experts on some invasive methods of HTN treatment — “DEVICE-BASED TREATMENT” (DBT) in the section of new recommendations of the European Societies of Cardiology/Hypertension (2018 ESC/ESH Guidelines for the management of arterial hypertension), including carotid baroreceptor stimulation, renal denervation, arteriovenous fistula formation and other. The experts do not recommend to use DBT in routine practice, confirm high requirement and demand of clinical and basic investigations to prove their safety and efficiency.
About the Authors
T. M. Ripp
Cardiology Research Institute of the Tomsk National Research Medical Center.
Russian Federation
Russian Federation
MD, PhD, DSc, Senior Researcher, Arterial Hypertension Department, Cardiology Research Institute, Tomsk National Research Medical Center.
111a Kievskaya street, Tomsk, 634012.
V. F. Mordovin
Cardiology Research Institute of the Tomsk National Research Medical Center.
Russian Federation
Russian Federation
MD, PhD, DSc, Professor, Head, Arterial Hypertension Department, Cardiology Research Institute, Tomsk National Research Medical Center.
111a Kievskaya street, Tomsk, 634012.
References
1. Williams B, Mancia G, Spiering W. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39:3021–3104. doi:10.1093/eurheartj/ehy339.
2. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial. J Am Coll Cardiol. 2011 Aug 9;58(7):765-73. doi: 10.1016/j.jacc.2011.06.008.
3. Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens/ 2016;34:1639–1647. doi: 10.1097/HJH.0000000000000977.
4. Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S., Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Bohm M, Spyral HTN-OFF Med trial investigators. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTNOFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160–2170. doi: 10.1016/S0140-6736(17)32281-X.
5. Звартау, НЭ, Конради АО. Интервенционные подходы к лечению артериальной гипертензии. Артериальная гипертензия. 2015;21(5):451–458. https://doi.org/10.18705/1607-419X-2015-21-5-450-458. [Zvartau N.E., Konradi A.O. Update on interventional approaches to treatment of hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2015;21(5):450-458. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-5-450-458].
6. Coppolino G, Pisano A, Rivoli L, Bolignano D. Renal denervation for resistant hypertension. Cochrane Database Syst Rev. 2017 Feb 21;2:CD011499. doi: 10.1002/14651858.CD011499.pub2.
7. Saxena M, Sobotka PA, Hamshere SM, Jain A, Mathur A, Knight C, Collier D.J., Lobo M.D. Antihypertensive effects of a central arteriovenous anastomosis are mediated through profound reduction in systemic vascular resistance. Circ Cardiovasc Interv. 2016 Aug;9(8):e004012. doi: 10.1161/CIRCINTERVENTIONS.116.004012.
Review
For citations:
Ripp T.M., Mordovin V.F. 2018 ESC/ESH guidelines about new methods of treatment of hypertension — “DEVICE-BASED TREATMENT”. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2018;24(6):623-627. (In Russ.) https://doi.org/10.18705/1607-419X-2018-24-6-623-627
Views:
3448
Email this article 